Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (34)

  1. . Human Drug Metabolism. .
    https://doi.org/10.1002/9781119658016.ch7
  2. Kyung Ho Lee, Won-Myong Bahk, Soo-Jung Lee, Chi-Un Pae. Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice. Clin Psychopharmacol Neurosci 2020;18:621
    https://doi.org/10.9758/cpn.2020.18.4.621
  3. A. Baldacci, E. Saguin, S. Annette, B. Lahutte, M.-D. Colas, H. Delacour. Pharmacogénétique des cytochromes appliquée à la prescription des antidépresseurs : mode d’emploi. L'Encéphale 2022;48:462
    https://doi.org/10.1016/j.encep.2021.12.008
  4. Filip Milosavljević, Prof. Espen Molden, Prof. Magnus Ingelman-Sundberg, Assoc. Prof. Marin M Jukić. Current level of evidence for improvement of antidepressant efficacy and tolerability by pharmacogenomic-guided treatment: A Systematic review and meta-analysis of randomized controlled clinical trials. European Neuropsychopharmacology 2024;81:43
    https://doi.org/10.1016/j.euroneuro.2024.01.005
  5. Teuntje A. D. Pelgrim, Alexandra Philipsen, Allan H. Young, Mario Juruena, Ester Jimenez, Eduard Vieta, Marin Jukić, Erik Van der Eycken, Urs Heilbronner, Ramona Moldovan, Martien J. H. Kas, Raj R. Jagesar, Markus M. Nöthen, Per Hoffmann, Noam Shomron, Laura L. Kilarski, Thérèse van Amelsvoort, Bea Campforts, Roos van Westrhenen. A New Intervention for Implementation of Pharmacogenetics in Psychiatry: A Description of the PSY-PGx Clinical Study. Pharmaceuticals 2024;17:151
    https://doi.org/10.3390/ph17020151
  6. Marin Jukic, Filip Milosavljević, Espen Molden, Magnus Ingelman-Sundberg. Pharmacogenomics in treatment of depression and psychosis: an update. Trends in Pharmacological Sciences 2022;43:1055
    https://doi.org/10.1016/j.tips.2022.09.011
  7. Changsu Han, Sheng-Min Wang, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand, Chi-Un Pae. The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study. Clin Psychopharmacol Neurosci 2019;17:495
    https://doi.org/10.9758/cpn.2019.17.4.495
  8. Yu Cheng, Hongmei Liu, Ruixue Yuan, Kai Yuan, Shunying Yu. Effectiveness of pharmacogenomics on the response and remission of treatment-resistant depression: a meta-analysis of randomised controlled trials. Gen Psych 2023;36:e101050
    https://doi.org/10.1136/gpsych-2023-101050
  9. Kyung Ho Lee, Geun-Young Park, Won-Myong Bahk, Soo-Jung Lee, Chi-Un Pae. The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis. Clin Psychopharmacol Neurosci 2020;18:445
    https://doi.org/10.9758/cpn.2020.18.3.445
  10. Benjamin Laplace, Benjamin Calvet, Aurelie Lacroix, Stephane Mouchabac, Nicolas Picard, Murielle Girard, Eric Charles. Acceptability of Pharmacogenetic Testing among French Psychiatrists, a National Survey. JPM 2021;11:446
    https://doi.org/10.3390/jpm11060446
  11. Kristian Kleine Schaars, Roos van Westrhenen. Pharmacogenomics and the Management of Mood Disorders—A Review. JPM 2023;13:1183
    https://doi.org/10.3390/jpm13071183
  12. Jennifer Severe, John F. Greden, Priyanka Reddy. Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?. FOC 2020;18:120
    https://doi.org/10.1176/appi.focus.20200008
  13. Joshua Russell, Meghan J. Arwood, Nicole M. Del Toro-Pagán, Nishita S. Amin, Michele D. Cambridge, Jacques Turgeon, Veronique Michaud. Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall. Medicina 2023;59:118
    https://doi.org/10.3390/medicina59010118
  14. Stefano Barlati, Alessandra Minelli, Gabriele Nibbio, Lorenzo Bertoni, Nicola Necchini, Stefano Paolini, Alessia Muscarella, Ughetta Bosco Ubertino, Irene Calzavara-Pinton, Antonio Vita, Massimo Gennarelli. The role of pharmacogenetics in the treatment of major depressive disorder: a critical review. Front. Psychiatry 2023;14
    https://doi.org/10.3389/fpsyt.2023.1307473
  15. Lisa C. Brown, Joseph D. Stanton, Kanika Bharthi, Abdullah Al Maruf, Daniel J. Müller, Chad A. Bousman. Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta‐Analysis of Prospective, Controlled Clinical Trials. Clin Pharma and Therapeutics 2022;112:1303
    https://doi.org/10.1002/cpt.2748
  16. Alessandra Minelli, Stefano Barlati, Bernhard T Baune. Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review. European Neuropsychopharmacology 2022;59:68
    https://doi.org/10.1016/j.euroneuro.2022.04.007
  17. Gualberto Ruaño, Theodore Holford, Richard L. Seip, John W. Goethe, Raveen Mehendru. Pharmacogenetic clinical decision support for psychiatric hospitalization: Design of the CYP-GUIDES randomized controlled trial. Contemporary Clinical Trials 2019;83:27
    https://doi.org/10.1016/j.cct.2019.06.008
  18. Shimaa Aboelbaha, Monica Zolezzi, Hazem Elewa. Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review. NDT 2021;Volume 17:2397
    https://doi.org/10.2147/NDT.S312966
  19. Jae-Min Kim, Robert Stewart, Hee-Ju Kang, Ju-Wan Kim, Hee-Joon Lee, Min Jhon, Ju-Yeon Lee, Sung-Wan Kim, Il-Seon Shin. Predictors of relapse following a stepwise psychopharmacotherapy regime in patients with depressive disorders. Journal of Affective Disorders 2021;293:109
    https://doi.org/10.1016/j.jad.2021.06.015
  20. Wolfgang Marx, Brenda W. J. H. Penninx, Marco Solmi, Toshi A. Furukawa, Joseph Firth, Andre F. Carvalho, Michael Berk. Major depressive disorder. Nat Rev Dis Primers 2023;9
    https://doi.org/10.1038/s41572-023-00454-1
  21. Kyung Ho Lee, Won-Myong Bahk, Soo-Jung Lee, Alessandro Serretti, Chi-Un Pae. A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat. Clin Psychopharmacol Neurosci 2021;19:160
    https://doi.org/10.9758/cpn.2021.19.1.160
  22. Antoine Baldacci, Emeric Saguin, Alexander Balcerac, Stéphane Mouchabac, Florian Ferreri, Raphael Gaillard, Marie-Dominique Colas, Hervé Delacour, Alexis Bourla. Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice. Pharmaceutics 2023;15:2540
    https://doi.org/10.3390/pharmaceutics15112540
  23. Danilo Arnone, Omar Omar, Teresa Arora, Linda Östlundh, Reshma Ramaraj, Syed Javaid, Romona Devi Govender, Bassam R. Ali, George P. Patrinos, Allan H. Young, Emmanuel Stip. Effectiveness of pharmacogenomic tests including CYP2D6 and CYP2C19 genomic variants for guiding the treatment of depressive disorders: Systematic review and meta-analysis of randomised controlled trials. Neuroscience & Biobehavioral Reviews 2023;144:104965
    https://doi.org/10.1016/j.neubiorev.2022.104965
  24. Iván Sánchez-Iglesias, Celia Martín-Aguilar. Significant Differences and Experimental Designs Do Not Necessarily Imply Clinical Relevance: Effect Sizes and Causality Claims in Antidepressant Treatments. JCM 2023;12:3181
    https://doi.org/10.3390/jcm12093181
  25. Mary Bunka, Gavin Wong, Dan Kim, Louisa Edwards, Jehannine Austin, Mary M. Doyle-Waters, Andrea Gaedigk, Stirling Bryan. Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis. Psychiatry Research 2023;321:115102
    https://doi.org/10.1016/j.psychres.2023.115102
  26. Vilches, Tuson, Vieta, Álvarez, Espadaler. Effectiveness of a Pharmacogenetic Tool at Improving Treatment Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Clinical Studies. Pharmaceutics 2019;11:453
    https://doi.org/10.3390/pharmaceutics11090453
  27. Dan V. Iosifescu. Pharmacogenomic Testing for Next-Step Antidepressant Selection. JAMA 2022;328:146
    https://doi.org/10.1001/jama.2022.10018
  28. Evangelia Eirini Tsermpini, Alessandro Serretti, Vita Dolžan. Precision Medicine. 2022.
    https://doi.org/10.1007/164_2023_654
  29. Andy R. Eugene. Optimizing drug selection in psychopharmacology based on 40 significant CYP2C19- and CYP2D6-biased adverse drug reactions of selective serotonin reuptake inhibitors. 2019;7:e7860
    https://doi.org/10.7717/peerj.7860
  30. Gerard Anmella, Silvia Vilches, Jordi Espadaler-Mazo, Andrea Murru, Isabella Pacchiarotti, Miquel Tuson, Marina Garriga, Eva Solé, Mercè Brat, Giovanna Fico, Eduard Vieta. Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression. Genes 2021;12:1259
    https://doi.org/10.3390/genes12081259
  31. Xinrui Wang, Chenfei Wang, Yi Zhang, Zhuoling An. Effect of pharmacogenomics testing guiding on clinical outcomes in major depressive disorder: a systematic review and meta-analysis of RCT. BMC Psychiatry 2023;23
    https://doi.org/10.1186/s12888-023-04756-2
  32. Marta Ielmini, Ivano Caselli, Flavio Critelli, Michele Mattia, Alessandro Bellini, Camilla Callegari. Efficacy and tolerability of therapies set under pharmacogenetic tools suggestions: A systematic review with meta-analysis about mood disorders. Psychiatry Research 2022;311:114482
    https://doi.org/10.1016/j.psychres.2022.114482
  33. Céline K. Stäuble, Markus L. Lampert, Samuel Allemann, Martin Hatzinger, Kurt E. Hersberger, Henriette E. Meyer zu Schwabedissen, Christian Imboden, Thorsten Mikoteit. Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial. Trials 2021;22
    https://doi.org/10.1186/s13063-021-05724-5
  34. Samantha Medwid, Richard B. Kim. Implementation of pharmacogenomics: Where are we now?. Brit J Clinical Pharma 2022
    https://doi.org/10.1111/bcp.15591